Tablet-based Aphasia Therapy in the Acute Phase After Stroke
NCT ID: NCT03679637
Last Updated: 2020-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2018-09-28
2019-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tablet-based Aphasia Therapy in the Chronic Phase
NCT03622411
Strategy Training for People With Aphasia After Stroke
NCT03593876
Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions
NCT01540383
Links Between Motor Abilities and Language Ability Deficits in Patients With Post-stroke Aphasia
NCT05776368
Predicting Language Recovery in Acute Stroke Patients in the Neurovascular Intensive Care Unit: An Exploratory Study With the Core Assessment of Language Processing.
NCT06817642
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Each participant will receive a tablet-based aphasia therapy
Tablet-based aphasia therapy
patients will independently practice with a speech app during hospitalisation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tablet-based aphasia therapy
patients will independently practice with a speech app during hospitalisation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Maximum 2 weeks post-stroke
* Minimum 18 years old
* A minimum proficient language level of Dutch
* Imaging (CT or MRI) prior to inclusion
* Signed informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Neurologie
Principal Investigator, clinical professor Veerle De Herdt
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veerle De Herdt
Role: PRINCIPAL_INVESTIGATOR
University Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital, department of neurology
Ghent, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
De Cock E, Batens K, Feiken J, Hemelsoet D, Oostra K, De Herdt V. The feasibility, usability and acceptability of a tablet-based aphasia therapy in the acute phase following stroke. J Commun Disord. 2021 Jan-Feb;89:106070. doi: 10.1016/j.jcomdis.2020.106070. Epub 2020 Dec 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC/2018/1006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.